{"id":"W3167507754","doi":"10.2147/copd.s294333","title":"Mepolizumab for Eosinophil-Associated COPD: Analysis of METREX and METREO","year":2021,"lang":"en","type":"review","venue":"International Journal of COPD","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":82,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"European Respiratory Society; GlaxoSmithKline; American Thoracic Society","keywords":"Mepolizumab; Medicine; Exacerbation; Internal medicine; Placebo; COPD; Clinical endpoint; Eosinophil; Randomized controlled trial; Hazard ratio; Confidence interval; Gastroenterology; Pathology; Asthma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01944257,0.002490883,0.01085631,0.001220801,0.0003226099,0.002212779,0.001521273,0.001530861,0.004637103],"category_scores_gemma":[0.01949114,0.001007302,0.04465904,0.001502005,0.0004964721,0.001230989,0.001357059,0.001941942,0.0004602598],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000951488,"about_ca_system_score_gemma":0.000791121,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001560114,"about_ca_topic_score_gemma":0.002864782,"domain_scores_codex":[0.9855447,0.01047642,0.001180999,0.001396044,0.0009763892,0.000425406],"domain_scores_gemma":[0.9846218,0.01027288,0.002733502,0.001294618,0.0006639578,0.0004133139],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","study_design_scores_codex":[0.09494282,0.00008918084,0.01674878,0.01081544,0.8642131,0.0001154114,0.00004858338,0.001516171,0.0009513657,0.0002152841,0.0005294961,0.009814277],"study_design_scores_gemma":[0.01748974,0.004355949,0.03483216,0.0008245059,0.9365129,0.000224632,0.00004138285,0.00241233,0.0003142879,0.0006244181,0.00231549,0.00005203881],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.4921679,0.490008,0.006783209,0.001615377,0.0006649559,0.0008318907,0.005295252,0.0002355609,0.002397745],"genre_scores_gemma":[0.977079,0.01654924,0.002094271,0.0007557447,0.0002602414,0.0003653645,0.001995844,0.00008180102,0.000818553],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.01944257,"threshold_uncertainty_score":0.1028234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05257673057627094,"score_gpt":0.41373496738615,"score_spread":0.361158236809879,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}